Story perspectives
Fifth Circuit Hears Mifepristone Rule Challenge, FDA Update Ordered
9/9/2026
1 of 1
Story summary
- The 5th U.S. Circuit Court of Appeals heard arguments on tightening mifepristone prescribing rules.
- Louisiana Attorney General Liz Murrill and plaintiff Rosalie Markezich argued the state lacks standing.
- A judge ordered the FDA to provide a mifepristone safety status update by Oct. 7.
- Survey by Society of Family Planning estimates 770-900 Louisiana women obtained out-state abortion pills each month in 2025.
